The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

M. Hutchinson, L. Kappos, P.A. Calabresi, C. Confavreux, G. Giovannoni, S.L. Galetta, E. Havrdova, F.D. Lublin, D. Miller, P.W. O'Connor, J.T. Phillips, C.H. Polman, E.W. Radue, R.A. Rudick, W.H. Stuart, A. Wajgt, B. Weinstock-Guttman, D.R. Wynn, F. Lynn, M.A. Panzara

Research output: Contribution to journalArticleAcademicpeer-review

94 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)405-415
JournalJournal of Neurology
Volume256
Issue number3
DOIs
Publication statusPublished - 2009

Cite this

Hutchinson, M., Kappos, L., Calabresi, P. A., Confavreux, C., Giovannoni, G., Galetta, S. L., ... Panzara, M. A. (2009). The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. Journal of Neurology, 256(3), 405-415. https://doi.org/10.1007/s00415-009-0093-1